Get started
Author

William Echavidre

ORCID: 0009-0008-6042-4522
Observed ORCID: 0009-0008-6042-4522
OpenAlex ID: A5071495296
Integrin-αvβ3 as a Therapeutic Target in Glioblastoma: Back to the Future?
2022 · William Echavidre, Vincent Picco, et al. · Pharmaceutics · 71
PDF
Recent Pre-Clinical Advancements in Nuclear Medicine: Pioneering the Path to a Limitless Future
2023 · William Echavidre, Daniel Fagret, et al. · Cancers · 16
PDF
Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance
2023 · William Echavidre, Jérôme Durivault, et al. · Cancer Research Communications · 9
Exploiting Integrin-αVβ3 to Enhance Radiotherapy Efficacy in Medulloblastoma via Ferroptosis
2024 · Célia Gotorbe, Fabien Segui, et al. · Current Oncology · 4
PDF
Integrin β1 signaling at the crossroads of cellular plasticity, the tumor microenvironment, and therapy resistance in medulloblastoma
2026 · William Echavidre, Vincent Picco, et al. · Frontiers in Oncology
PDF
Ciblage des intégrines comme levier diagnostique et thérapeutique dans le médulloblastome : vers une médecine de précision en pédiatrie
2025 · William Echavidre · theses.fr (ABES)
Figure S6 from Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance
2023 · William Echavidre, Jérôme Durivault, et al.
PDF
FIGURE 3 from Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance
2023 · William Echavidre, Jérôme Durivault, et al.
FIGURE 6 from Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance
2023 · William Echavidre, Jérôme Durivault, et al.
FIGURE 4 from Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance
2023 · William Echavidre, Jérôme Durivault, et al.
Figure S2 from Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance
2023 · William Echavidre, Jérôme Durivault, et al.
FIGURE 1 from Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance
2023 · William Echavidre, Jérôme Durivault, et al.
Data from Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance
2023 · William Echavidre, Jérôme Durivault, et al.
FIGURE 2 from Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance
2023 · William Echavidre, Jérôme Durivault, et al.
Figure S5 from Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance
2023 · William Echavidre, Jérôme Durivault, et al.
PDF
Data from Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance
2023 · William Echavidre, Jérôme Durivault, et al.
FIGURE 5 from Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance
2023 · William Echavidre, Jérôme Durivault, et al.
Figure S4 from Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance
2023 · William Echavidre, Jérôme Durivault, et al.
Table S1 from Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance
2023 · William Echavidre, Jérôme Durivault, et al.
PDF
Figure S8 from Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance
2023 · William Echavidre, Jérôme Durivault, et al.
Figure S3 from Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance
2023 · William Echavidre, Jérôme Durivault, et al.
Figure S7 from Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance
2023 · William Echavidre, Jérôme Durivault, et al.
PDF
Figure S1 from Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance
2023 · William Echavidre, Jérôme Durivault, et al.
PDF
Figure S7 from Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance
2023 · William Echavidre, Jérôme Durivault, et al.
Works count: 24
Citation count: 100
H-index: 4
I10-index: 2
Year
Topic
Type